Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Non-interventional, Multi-centre Study to Investigate the Change in Patient-reported Outcomes in Moderate to Severe COPD Patients Newly Initiated on TRIXEO AEROSPHERE (Budesonide/Glycopyrronium/Formoterol) in Real-life Setting in Romania

NCT06368427 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT06368427
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06368427 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Non-interventional, Multi-centre Study to Investigate the Change in Patient-reported Outcomes in Moderate to Severe COPD Patients Newly Initiated on TRIXEO AEROSPHERE (Budesonide/Glycopyrronium/Formoterol) in Real-life Setting in Romania
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
April 30, 2024
Completion date
November 17, 2025
Enrollment
10 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease (copd)